Violeta Sánchez
Impact in
- Oncology top 1%
- HER2/EGFR in Cancer Research
- Cancer Cells and Metastasis
- Cancer-related Molecular Pathways
- Cancer Immunotherapy and Biomarkers
- Cancer Research top 2%
- Cancer, Hypoxia, and Metabolism
Papers in
- Oncology 40
- HER2/EGFR in Cancer Research 19
- Cancer Immunotherapy and Biomarkers 12
- Cancer Cells and Metastasis 7
- Cancer-related Molecular Pathways 6
-
- PI3K/AKT/mTOR signaling in cancer 12
- Co-authors
- Carlos L. Arteaga (24 shared papers)Justin M. Balko (29 shared papers)Melinda E. Sanders (25 shared papers)Rebecca S. Cook (21 shared papers)Cammie Rinehart (5 shared papers)Anindita Chakrabarty (3 shared papers)María G. Kuba (8 shared papers)Paula I. González-Ericsson (26 shared papers)
- Journals
- Cancer Research (15 papers)Clinical Cancer Research (7 papers)Proceedings of the National Academy of Sciences (4 papers)Breast Cancer Research (3 papers)Journal of Clinical Investigation (2 papers)
- Partner nations
- United StatesAustraliaPeru
In The Last Decade
Violeta Sánchez
54 papers receiving 3.7k citations
Violeta Sánchez's Hit Papers
Peers
Comparison fields: 5 of 98
- Oncology 2.1k
- Cancer Research 840
- Molecular Biology 2.1k
- Immunology 601
- Genetics 294
Countries citing papers authored by Violeta Sánchez
This map shows the geographic impact of Violeta Sánchez's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Violeta Sánchez with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Violeta Sánchez more than expected).
Fields of papers citing papers by Violeta Sánchez
This network shows the impact of papers produced by Violeta Sánchez. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Violeta Sánchez. The network helps show where Violeta Sánchez may publish in the future.
Co-authors
The 25 scholars most cited alongside Violeta Sánchez, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 59 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | MYC and MCL1 Cooperatively Promote Chemotherapy-Resistant Breast Cancer Stem Cells via Regulation of Mitochondrial Oxidative Phosphorylation Hit paper breakdown → | 2017 | 479 |
| 2 | TGF-β inhibition enhances chemotherapy action against triple-negative breast cancer Hit paper breakdown → | 2013 | 475 |
| 3 | 2011 | 359 | |
| 4 | 2011 | 276 | |
| 5 | 2018 | 191 | |
| 6 | 2017 | 171 | |
| 7 | 2013 | 147 | |
| 8 | 2018 | 133 | |
| 9 | 2011 | 131 | |
| 10 | 2019 | 113 | |
| 11 | 2012 | 104 | |
| 12 | 2009 | 99 | |
| 13 | 2017 | 78 | |
| 14 | 2016 | 69 | |
| 15 | 2009 | 69 | |
| 16 | 2018 | 68 | |
| 17 | 2018 | 65 | |
| 18 | 2011 | 64 | |
| 19 | 2017 | 56 | |
| 20 | 2018 | 54 |
About Violeta Sánchez
Violeta Sánchez is a scholar working on Oncology, Molecular Biology, Immunology, Radiology, Nuclear Medicine and Imaging and Pulmonary and Respiratory Medicine, having authored 59 papers that have together received 3.8k indexed citations. Recurring topics across this work include HER2/EGFR in Cancer Research (19 papers), Cancer Immunotherapy and Biomarkers (12 papers), PI3K/AKT/mTOR signaling in cancer (12 papers), Cancer Cells and Metastasis (7 papers), Cancer-related Molecular Pathways (6 papers), Immunotherapy and Immune Responses (6 papers), Monoclonal and Polyclonal Antibodies Research (6 papers) and Immune Cell Function and Interaction (4 papers). The work is most often cited by research in Oncology (2.1k citations), Cancer Research (840 citations), Molecular Biology (2.1k citations), Immunology (601 citations) and Genetics (294 citations). Violeta Sánchez has collaborated with scholars based in United States, Australia and Peru. Frequent co-authors include Carlos L. Arteaga, Justin M. Balko, Melinda E. Sanders, Rebecca S. Cook, Cammie Rinehart, Anindita Chakrabarty, María G. Kuba, Paula I. González-Ericsson, Jamie C. Stanford and Teresa C. Dugger. Their work appears in journals such as Cancer Research, Clinical Cancer Research, Proceedings of the National Academy of Sciences, Breast Cancer Research and Journal of Clinical Investigation.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.